Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relamorelin in Diabetic Gastroparesis (Study 03)
NCT03420781Phase 3Terminated
- Sponsor
- Allergan
- Start
- Jan 2018
- Primary completion
- Oct 2020
- Modality
- Peptides, Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of relamorelin in diabetic gastroparesis, sponsored by Allergan. Started Jan 2018; status: terminated.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT03420781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420781.